Corient Capital Partners, LLC Bristol Myers Squibb CO Transaction History

Corient Capital Partners, LLC

$1.34 Billion
Q3 2022

A detailed history of Corient Capital Partners, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Corient Capital Partners, LLC holds 84,777 shares of BMY stock, worth $4.99 Million. This represents 0.49% of its overall portfolio holdings.

Number of Shares

84,777

Previous 84,777 -0.0%

Holding current value

$4.99 Million

Previous $6.53 Million -0.0%

% of portfolio

0.49%

Previous 0.49%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	BUY	$72.62 - $79.98 $341,967 - $376,625	4,709 Added 5.88%	84,777 $6.53 Million
Q1 2022 May 16, 2022	BUY	$61.48 - $73.72 $433,556 - $519,873	7,052 Added 9.66%	80,068 $5.85 Million
Q4 2021 Feb 11, 2022	BUY	$53.63 - $62.52 $334,436 - $389,874	6,236 Added 9.34%	73,016 $4.55 Million
Q3 2021 Nov 16, 2021	SELL	$59.17 - $69.31 $11,005 - $12,891	-186 Reduced 0.28%	66,780 $3.95 Million
Q2 2021 Aug 16, 2021	SELL	$61.91 - $67.42 $19,130 - $20,832	-309 Reduced 0.46%	66,966 $4.48 Million
Q1 2021 May 17, 2021	SELL	$59.34 - $66.74 $2,967 - $3,336	-50 Reduced 0.07%	67,275 $4.25 Million
Q4 2020 Feb 12, 2021	BUY	$57.74 - $65.43 $85,339 - $96,705	1,478 Added 2.24%	67,325 $4.18 Million
Q3 2020 Nov 16, 2020	BUY	$57.43 - $63.64 $152,017 - $168,455	2,647 Added 4.19%	65,847 $3.97 Million
Q2 2020 Aug 14, 2020	BUY	$54.82 - $64.09 $107,008 - $125,103	1,952 Added 3.19%	63,200 $3.72 Million
Q1 2020 May 06, 2020	BUY	$46.4 - $67.43 $255,617 - $371,471	5,509 Added 9.88%	61,248 $3.41 Million
Q4 2019 Feb 04, 2020	BUY	$49.21 - $64.19 $1.73 Million - $2.25 Million	35,111 Added 170.21%	55,739 $3.58 Million
Q3 2019 Nov 06, 2019	BUY	$42.77 - $50.71 $373,724 - $443,103	8,738 Added 73.49%	20,628 $1.05 Million
Q2 2019 Aug 08, 2019	BUY	$44.62 - $49.34 $128,282 - $141,852	2,875 Added 31.89%	11,890 $540,000
Q1 2019 May 10, 2019	BUY	$45.12 - $53.8 $5,730 - $6,832	127 Added 1.43%	9,015 $431,000
Q4 2018 Feb 07, 2019	BUY	$48.76 - $63.23 $162,419 - $210,619	3,331 Added 59.94%	8,888 $462,000
Q2 2018 Oct 02, 2018	BUY	$50.53 - $62.98 $94,491 - $117,772	1,870 Added 50.72%	5,557 $307,000
Q1 2018 May 14, 2018	SELL	$59.92 - $68.98 $26,364 - $30,351	-440 Reduced 10.66%	3,687 $233,000
Q4 2017 Feb 13, 2018	SELL	$59.94 - $65.35 $15,224 - $16,598	-254 Reduced 5.8%	4,127 $253,000
Q3 2017 Nov 14, 2017	SELL	$55.23 - $63.74 $36,783 - $42,450	-666 Reduced 13.2%	4,381 $0
Q2 2017 Aug 14, 2017	SELL	N/A	-78 Reduced 1.52%	5,047 $281,000
Q1 2017 Aug 17, 2017	SELL	N/A	-13,637 Reduced 72.68%	5,125 $279,000
Q1 2017 Aug 14, 2017	BUY	N/A	18,762	18,762 $242,000

Others Institutions Holding BMY

# of Institutions

2,533

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $125B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Corient Capital Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Corient Capital Partners, LLC with notifications on news.

Account

Corient Capital Partners, LLC Bristol Myers Squibb CO Transaction History